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ABSTRACT
Background: Cervical involvement by endometrial cancer
alters the FIGO stage and determines clinical manage-
ment, but there are no accepted guidelines for cervical
sampling of these cases.
Aim: To assess whether sampling more than two
‘‘routine’’ blocks of the cervix (anterior and posterior)
alters the pathological staging of hysterectomy specimens
for endometrial cancer.
Methods: Histological involvement of the cervix was
prospectively compared in hysterectomies performed for
proven endometrial cancer (n = 61). Specimens had two
‘‘routine’’ blocks taken from anterior and posterior cervix;
all of the remaining cervix was also processed for
histological assessment.
Results: 61 cases of endometrial cancer had the entire
uterine cervix processed. There were 54 cases of
endometrioid adenocarcinoma and 7 special types.
Twelve cases had cervical involvement (stage 2A or 2B),
and seven cases were stage 3A or above, of which three
also had cervical involvement. In none of the 61 cases did
the additional cervical blocks (n = 544) taken alter the
staging made on the ‘‘routine’’ blocks.
Conclusion: Sampling of two blocks from the cervix
appears sufficient for histological staging of endometrial
cancer in hysterectomy specimens.
Endometrial cancer is the commonest uterine
malignancy worldwide, and is the fifth commonest
female neoplasm in England, accounting for 5029
cases in 2004.1 Accurate pathological assessment is
essential for clinical decision making, and the
criteria for staging are outlined in FIGO guidelines.2
In FIGO staging, it is essential to assess the spread
of endometrial cancer within the hysterectomy
specimen, both for involvement of the myome-
trium, but also to detect possible spread into
the cervix and serosal surfaces. The difference
potentially between stage 1 and stage 2 disease is
critical in that treatment options would (in most
centres) differ between essentially watchful wait-
ing for stage 1 as opposed to pelvic radiotherapy for
stage 2.3 The pathology guidelines for how to
assess cervical involvement in such cases are
outlined in peer produced and assessed protocols,4 5
but the evidence base for these with respect to how
a histopathologist should sample the cervix is
difficult to find, if indeed it exists. Green and
Heatley6 investigated hysterectomies from women
with a history of previous cervical abnormalities;
routine cervical sampling with one block from the
anterior and one from the posterior cervix was
sufficient to ensure that potentially significant
pathology was not missed, although in some
circumstances more extensive sampling of the
cervix may be appropriate. Whether these results
can be extrapolated to non-benign hysterectomies
is unknown. The Queen Elizabeth Hospital oper-
ates as a regional gynaecological oncology referral
centre for the northern part of the North East of
England, covering a total population of approxi-
mately two million. As such, endometrial cancer is
encountered frequently, and histology slides
from many other units are routinely reviewed.
From these reviews, it was evident that the
pathologists around the region differed in their
approach to sampling of the cervix with several
approaches: two routine anterior/posterior blocks
only or anterior/posterior blocks and further
blocks (or all) of the cervix with or without
transverse blocks of the upper endocervical canal.
This variation led us to compare prospectively
histological findings in two ‘‘routine’’ anterior/
posterior cervical blocks versus sampling of the
entire cervix, in order to assess whether taking
additional blocks would affect the staging of
endometrial cancer.
Table 1 Details of cases by histological type, grade and stage (n = 61)
IA IB IC 2A 2B 3A 3B 3C IVA IVB
EG1 3 13 3 – 2 1 – – – –
EG2 – 7 6 2 6 1 – – – –
EG3 – 3 3 1 1 1 – 1 – –
UPSC – – 1 – – 1 – – 1 1
Clear cell – 1 1 – – – – – – –
Mucinous – 1 – – – – – – – –
Total 3 25 14 3 9 4 – 1 1 1
EG1/EG2/EG3, endometrioid adenocarcinoma grade 1, 2 or 3; UPSC, uterine papillary serous carcinoma; Clear cell, clear cell adenocarcinoma;
Mucinous, mucinous adenocarcinoma.
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MATERIALS AND METHODS
Endometrial cancers operated upon at the Northern
Gynaecological Oncology Centre (NGOC), Queen Elizabeth
Hospital, Gateshead, the Royal Victoria Infirmary (RVI),
Newcastle upon Tyne, and Nottingham University Hospital
(NUH), Nottingham, were prospectively identified. Cases were
staged in accordance with FIGO guidelines (peritoneal washings
in all cases, with lymph nodes and/or peritoneal/omental
biopsies as clinically indicated). All hysterectomy cases (irre-
spective of the original diagnosis of grade or potential stage) had
routine blocks taken for assessment of disease spread (endome-
trium, myometrium, adnexae if present). One block each was
taken from the anterior and posterior cervix (‘‘routine’’), but in
addition the entire cervix was then processed as well as
transverse blocks from the upper endocervical canal. The two
‘‘routine’’ blocks were identified to allow assessment against the
extra blocks taken from the cervix. During the period of the
study (January 2005–May 2007), cases were identified and
processed as above from the NGOC, RVI and NUH. Slides were
then reviewed and assessed by three of the authors (AGN, AES
or SD), depending on the site. Any potential problems or
assessment difficulties were resolved by multiheader microscope
discussion by consensus. Cases were discussed in the relevant
multidisciplinary meetings to achieve optimum recommenda-
tions for patient treatment.
RESULTS
During the study period, some 50–55% of hysterectomy
specimens with endometrial cancer were randomly selected
for processing (partly depending on the availability of study
pathologists) as described above, and were sampled according to
the protocol between the three sites. In addition to the routine
two cervical blocks, a range of 4–18 extra blocks were taken
(mean 9.4). The histological subtypes were endometrioid
adenocarcinoma (n = 54), uterine papillary serous carcinoma
(UPSC) (n = 4), clear cell carcinoma (n = 2), and mucinous
adenocarcinoma (n = 1). Table 1 shows details of grade, type
and histological FIGO stage. There were 12 cases with cervical
involvement, accounting for the three cases staged as FIGO
stage 2A and the nine staged as 2B. In all 12 cases cervical
involvement was seen in the two ‘‘routine’’ cervical blocks. The
additional blocks from the cervix did not add any significant
further information, although the features seen in the original
two blocks may have been more obvious in the extra blocks. Of
the seven cases staged as greater than FIGO stage 2B, three had
cervical involvement: again, in these cases, cervical involvement
was seen in the original two ‘‘routine’’ cervical blocks.
DISCUSSION
The correct staging of endometrial cancer in hysterectomy
specimens is essential to ensure correct patient management.
However, the lengths to which pathologists should go to assess
the cervix as part of pathological staging are not formally
specified. Hence variation between pathologists and potentially
wasted effort and resources may be widespread. Evidence exists
about the sampling of the cervix in hysterectomies following a
previous diagnosis of cervical intraepithelial neoplasia,6 but we
have been unable to identify similar evidence for the staging of
endometrial cancer. It is likely that involvement of the cervix by
endometrial adenocarcinoma is by direct spread or by implanta-
tion.7 Jordan and Al-Nafussi were looking in particular at
patterns of cervical involvement, and utilised a mean number of
2.51 cervical blocks per case from hysterectomy specimens.7 Our
current study did not aim to look at the pattern of spread per se,
but at what the optimum number of blocks may be to assess
any true cervical involvement as defined by FIGO. Our
relatively small study has shown that a single anterior and
posterior cervical block appears to be adequate for the staging of
endometrial cancer in hysterectomy. In no cases in the present
study did the extra blocks taken from the cervix show
significant additional pathology which would affect pathologi-
cal staging. It must be questioned whether the effort put into
sampling the extra material (a total of 544 additional blocks for
these 61 cases, at a mean of 8.9 extra blocks per case) is cost
effective. Given the pressures on histopathology departments,
this can have significant implications and cost for pathology
departments, where the workload for cancer reporting, of this or
of other types, may be onerous.8 This study would suggest that
use of a single anterior and posterior cervical tissue block is
adequate for the reporting and staging of endometrial cancer in
hysterectomy specimens.
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Take-home messages
c The reporting of hysterectomy specimens for endometrial
adenocarcinoma is common, but no real guidance exists on
how widely the cervix should be sampled to assess possible
cervical involvement.
c A prospective study of sampling the whole of the cervix
versus two routine blocks was undertaken.
c In none of the 61 cases studied did the extra cervical blocks
(544 in total) alter the histological opinion based on the two
routine blocks.
c It would appear unnecessary to take more than two routine
cervical histological blocks in these cases.
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